Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
E-M peptide
Potential treatment - theoretical effect Experimental Antiviral Oct/14/2020
Glycyrrhetinic acid
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/14/2020
Tomentodiplacone B
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Silydianin
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Eryvarin M
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Rhamnetin
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Osajin
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Raddeanine
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Neochlorogenic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Forsythoside I
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Forsythiaside
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Rhein
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
4-(2-aminomethyl)benzenesulfonyl fluoride
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/07/2020
Ramipril benzyl ester
Potential treatment - theoretical effect Experimental Antiviral Oct/06/2020
Lariciresinol
Potential treatment - theoretical effect Natural product Antiviral Oct/06/2020
Propafenone dimer
Potential treatment - theoretical effect Experimental Antiviral Oct/06/2020
L2 Azo imidazole
Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020
L1 Azo imidazole derivative
Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020
L4 Azo imidazole derivative
Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020
L3 Azo imidazole
Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020